- Preamble [SYSTEM]
- Fund & Investor Interest
- Street Moves
- Solebury Trout Updates
- Market Commentary
- IPO News
- Expert Interactions
- Banker Comments & Notes
- Conference Snippet
- Industry Snippets
- Social Media
- Solebury Trout Talks

IPO News: Forma Therapeutics File $150mm IPO
FORMA Therapeutics
Forma Therapeutics
NASDAQ: FMTX
Size: $150mm
Bookrunners: JEFF | LEER | CS
Major Holders: RA Capital | Novartis Bioventures | Baker Brothers | Lily Ventures
Description: Forma Therapeutics clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers
Reference Link: S-1